SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
Condition(s):Kidney CancerLast Updated:October 20, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Kidney CancerLast Updated:October 20, 2011Completed
Condition(s):Kidney CancerLast Updated:November 8, 2023Recruiting
Condition(s):Kidney CancerLast Updated:June 5, 2013Completed
Condition(s):Renal Cell CarcinomaLast Updated:August 29, 2011Completed
Condition(s):Renal Cell CarcinomaLast Updated:November 18, 2021Not yet recruiting
Condition(s):Kidney CancerLast Updated:September 26, 2012Completed
Condition(s):Kidney CancerLast Updated:November 7, 2019Completed
Condition(s):Healthy Subject; Metastatic Renal Cell Cancer; Recurrent Renal Cell Carcinoma; Stage I Renal Cell Cancer; Stage II Renal Cell Cancer; Stage III Renal Cell CancerLast Updated:November 8, 2023Active, not recruiting
Condition(s):Kidney CancerLast Updated:July 2, 2019Not yet recruiting
Condition(s):Kidney CancerLast Updated:March 5, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.